{"id":{"repo_id":"vt","oai_identifier":"oai:vtechworks.lib.vt.edu:10919/9790"},"canonical_url":"https://search.dev.ndltd.org/etd/vt/oai:vtechworks.lib.vt.edu:10919/9790","repository":{"repo_id":"vt","name":"Virginia Tech","base_url":"https://vtechworks.lib.vt.edu/oai/request"},"display":{"title":"Metabolic Studies on 1-Cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives by HPLC and LC-ESI/MS","abstract":"The MAO-B catalyzed metabolic bioactivation of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to generate the neurotoxic 1-methyl-4-phenylpyridinium species (MPP+) is well documented. The N-cyclopropyl analog (CPTP) of MPTP is a mechanism based inactivator of MAO-B which presumably is processed by a single electron transfer (SET) pathway to generate a bioalkylating species. These results have prompted us to study how the cytochromes P450, the major liver drug metabolizing oxidases, interact with N-cyclopropyl analogs of MPTP. HPLC with diode array detection and LC-electrosprary ionization mass spectrometry (LC-ESI/MS) based methods have been developed for metabolite detection and characterization. From the UV spectral data and pseudomolecular ion species observed by LC-ESI/MS, we have identified N-oxide, C-hydroxylated, and pyridinium metabolites. For the trans-1-(2-phenylcyclopropyl) analog, cinnamaldehyde and p-hydroxycinnamaldehyde also were characterized. Incubation of CPTP and its derivatives with cDNA expressed human hepatic cytochrome P450 has shown that CYP2D6 catalyzes the formation of cinnamaldehyde, the N-descyclopropyl, pyridinium and hydroxylated products. CYP3A4 is responsible for the formation of the N-descyclopropyl and pyridinium species and cinnamaldehyde but it does not mediate any hydroxylation reactions. Since both the a-carbon oxidation and N-descyclopropylation transformations are mediated by a single enzyme (either CYP2D6 or CYP3A4), we propose a common intermediate for both pathways, namely the cyclopropylaminyl radical cation generated by the SET pathway. This intermediate partitions between the a-carbon oxidation pathway leading to the dihydropyridinium and pyridinium species and the ring opening pathway leading to the N-descyclopropyl metabolite and aldehyde species. The phenyl substituent on the cyclopropyl ring stabilizes the ring opened distonic radical cation and favors the ring opening pathway and results in the formation of less of the pyridinium species. The proton and methyl substituents on the cyclopropyl ring favor the a-carbon oxidation pathway and increased amounts of the pyridinium species are formed.","abstract_html":"The MAO-B catalyzed metabolic bioactivation of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to generate the neurotoxic 1-methyl-4-phenylpyridinium species (MPP+) is well documented. The N-cyclopropyl analog (CPTP) of MPTP is a mechanism based inactivator of MAO-B which presumably is processed by a single electron transfer (SET) pathway to generate a bioalkylating species. These results have prompted us to study how the cytochromes P450, the major liver drug metabolizing oxidases, interact with N-cyclopropyl analogs of MPTP. HPLC with diode array detection and LC-electrosprary ionization mass spectrometry (LC-ESI/MS) based methods have been developed for metabolite detection and characterization. From the UV spectral data and pseudomolecular ion species observed by LC-ESI/MS, we have identified N-oxide, C-hydroxylated, and pyridinium metabolites. For the trans-1-(2-phenylcyclopropyl) analog, cinnamaldehyde and p-hydroxycinnamaldehyde also were characterized. Incubation of CPTP and its derivatives with cDNA expressed human hepatic cytochrome P450 has shown that CYP2D6 catalyzes the formation of cinnamaldehyde, the N-descyclopropyl, pyridinium and hydroxylated products. CYP3A4 is responsible for the formation of the N-descyclopropyl and pyridinium species and cinnamaldehyde but it does not mediate any hydroxylation reactions. Since both the a-carbon oxidation and N-descyclopropylation transformations are mediated by a single enzyme (either CYP2D6 or CYP3A4), we propose a common intermediate for both pathways, namely the cyclopropylaminyl radical cation generated by the SET pathway. This intermediate partitions between the a-carbon oxidation pathway leading to the dihydropyridinium and pyridinium species and the ring opening pathway leading to the N-descyclopropyl metabolite and aldehyde species. The phenyl substituent on the cyclopropyl ring stabilizes the ring opened distonic radical cation and favors the ring opening pathway and results in the formation of less of the pyridinium species. The proton and methyl substituents on the cyclopropyl ring favor the a-carbon oxidation pathway and increased amounts of the pyridinium species are formed.","abstract_has_math":false,"creators":["Shang, Xueqin"],"institution":"Virginia Tech","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Chemistry","degree_department":"Chemistry","school":null,"contributors":[],"advisors":[],"committee_chairs":["Castagnoli, Neal Jr."],"committee_members":["Anderson, Mark R."],"year":1999,"date_issued":"1999-07-23","date_published":"1999-07-23","updated_at":"2026-07-22T22:19:16Z","subjects":["cyclopropylaminyl radical cations","biotransformation","cytochrome P450","single electron transfer","HPLC","LC/MS"],"languages":[],"rights":["In Copyright"],"rights_urls":["http://rightsstatements.org/vocab/InC/1.0/"],"identifier_entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-080999-102837"],"render_values":[{"text":"etd-080999-102837","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10919/9790","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.committeechair","label":"Committee Chair","values":["Castagnoli, Neal Jr."]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Anderson, Mark R."]},{"key":"dc:contributor.department","label":"Department","values":["Chemistry"]},{"key":"dc:creator","label":"Author","values":["Shang, Xueqin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2011-08-06T14:49:35Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2011-08-06T14:49:35Z","2000-08-11"]},{"key":"dc:date.issued","label":"Date","values":["1999-07-23"]},{"key":"dc:publisher","label":"Institution","values":["Virginia Tech"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Virginia Polytechnic Institute and State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["cyclopropylaminyl radical cations","biotransformation","cytochrome P450","single electron transfer","HPLC","LC/MS"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://rightsstatements.org/vocab/InC/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-080999-102837"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10919/9790"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The MAO-B catalyzed metabolic bioactivation of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to generate the neurotoxic 1-methyl-4-phenylpyridinium species (MPP+) is well documented. The N-cyclopropyl analog (CPTP) of MPTP is a mechanism based inactivator of MAO-B which presumably is processed by a single electron transfer (SET) pathway to generate a bioalkylating species. These results have prompted us to study how the cytochromes P450, the major liver drug metabolizing oxidases, interact with N-cyclopropyl analogs of MPTP. HPLC with diode array detection and LC-electrosprary ionization mass spectrometry (LC-ESI/MS) based methods have been developed for metabolite detection and characterization. From the UV spectral data and pseudomolecular ion species observed by LC-ESI/MS, we have identified N-oxide, C-hydroxylated, and pyridinium metabolites. For the trans-1-(2-phenylcyclopropyl) analog, cinnamaldehyde and p-hydroxycinnamaldehyde also were characterized. Incubation of CPTP and its derivatives with cDNA expressed human hepatic cytochrome P450 has shown that CYP2D6 catalyzes the formation of cinnamaldehyde, the N-descyclopropyl, pyridinium and hydroxylated products. CYP3A4 is responsible for the formation of the N-descyclopropyl and pyridinium species and cinnamaldehyde but it does not mediate any hydroxylation reactions. Since both the a-carbon oxidation and N-descyclopropylation transformations are mediated by a single enzyme (either CYP2D6 or CYP3A4), we propose a common intermediate for both pathways, namely the cyclopropylaminyl radical cation generated by the SET pathway. This intermediate partitions between the a-carbon oxidation pathway leading to the dihydropyridinium and pyridinium species and the ring opening pathway leading to the N-descyclopropyl metabolite and aldehyde species. The phenyl substituent on the cyclopropyl ring stabilizes the ring opened distonic radical cation and favors the ring opening pathway and results in the formation of less of the pyridinium species. The proton and methyl substituents on the cyclopropyl ring favor the a-carbon oxidation pathway and increased amounts of the pyridinium species are formed."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science"]},{"key":"dc:format.medium","label":"Dc Format Medium","values":["ETD"]},{"key":"dc:title","label":"Title","values":["Metabolic Studies on 1-Cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives by HPLC and LC-ESI/MS"]}]}],"canonical_facts":{"dc:contributor.committeechair":["Castagnoli, Neal Jr."],"dc:contributor.committeemember":["Anderson, Mark R."],"dc:contributor.department":["Chemistry"],"dc:creator":["Shang, Xueqin"],"dc:date.accessioned":["2011-08-06T14:49:35Z"],"dc:date.available":["2011-08-06T14:49:35Z","2000-08-11"],"dc:date.issued":["1999-07-23"],"dc:description.abstract":["The MAO-B catalyzed metabolic bioactivation of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to generate the neurotoxic 1-methyl-4-phenylpyridinium species (MPP+) is well documented. The N-cyclopropyl analog (CPTP) of MPTP is a mechanism based inactivator of MAO-B which presumably is processed by a single electron transfer (SET) pathway to generate a bioalkylating species. These results have prompted us to study how the cytochromes P450, the major liver drug metabolizing oxidases, interact with N-cyclopropyl analogs of MPTP. HPLC with diode array detection and LC-electrosprary ionization mass spectrometry (LC-ESI/MS) based methods have been developed for metabolite detection and characterization. From the UV spectral data and pseudomolecular ion species observed by LC-ESI/MS, we have identified N-oxide, C-hydroxylated, and pyridinium metabolites. For the trans-1-(2-phenylcyclopropyl) analog, cinnamaldehyde and p-hydroxycinnamaldehyde also were characterized. Incubation of CPTP and its derivatives with cDNA expressed human hepatic cytochrome P450 has shown that CYP2D6 catalyzes the formation of cinnamaldehyde, the N-descyclopropyl, pyridinium and hydroxylated products. CYP3A4 is responsible for the formation of the N-descyclopropyl and pyridinium species and cinnamaldehyde but it does not mediate any hydroxylation reactions. Since both the a-carbon oxidation and N-descyclopropylation transformations are mediated by a single enzyme (either CYP2D6 or CYP3A4), we propose a common intermediate for both pathways, namely the cyclopropylaminyl radical cation generated by the SET pathway. This intermediate partitions between the a-carbon oxidation pathway leading to the dihydropyridinium and pyridinium species and the ring opening pathway leading to the N-descyclopropyl metabolite and aldehyde species. The phenyl substituent on the cyclopropyl ring stabilizes the ring opened distonic radical cation and favors the ring opening pathway and results in the formation of less of the pyridinium species. The proton and methyl substituents on the cyclopropyl ring favor the a-carbon oxidation pathway and increased amounts of the pyridinium species are formed."],"dc:description.degree":["Master of Science"],"dc:format.medium":["ETD"],"dc:identifier.other":["etd-080999-102837"],"dc:identifier.uri":["http://hdl.handle.net/10919/9790"],"dc:publisher":["Virginia Tech"],"dc:rights":["In Copyright"],"dc:rights.uri":["http://rightsstatements.org/vocab/InC/1.0/"],"dc:subject":["cyclopropylaminyl radical cations","biotransformation","cytochrome P450","single electron transfer","HPLC","LC/MS"],"dc:title":["Metabolic Studies on 1-Cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives by HPLC and LC-ESI/MS"],"dc:type":["Thesis"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Virginia Polytechnic Institute and State University"]},"updated_at":"2026-07-22T22:19:16Z"}